These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7060312)

  • 21. Hemodynamic effects of nitroprusside and furosemide in left ventricular failure.
    Franciosa JA; Silverstein SR
    Clin Pharmacol Ther; 1982 Jul; 32(1):62-9. PubMed ID: 7083731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium nitroprusside therapy in congestive cardiomyopathy-variability in hemodynamic response.
    Mookherjee S; Henion W; Warner R; Eich RH; Smulyan H; Obeid AI
    J Clin Pharmacol; 1978 Jan; 18(1):67-75. PubMed ID: 338648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodynamic effects of sodium nitroprusside in patients with ventricular septal defect.
    Subramanyam R; Tandon R; Shrivastava S
    Eur J Pediatr; 1982 Jul; 138(4):307-10. PubMed ID: 7128637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined vasodilator therapy for chronic congestive heart failure.
    Cody RJ; Franklin KW; Laragh JH
    Am Heart J; 1983 Apr; 105(4):575-80. PubMed ID: 6340448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulatory response to vasodilator therapy in congestive cardiomyopathy.
    Rossen RM; Alderman EL; Harrison DC
    Br Heart J; 1976 Jul; 38(7):695-700. PubMed ID: 973893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hemodynamic shifts in patients with congestive heart failure during treatment with sodium nitroprusside].
    Tatishvili NI; Chkhaidze ZK; Kurashvili RB; Mamatsashvili MD; Narsiia NN
    Kardiologiia; 1983 Jul; 23(7):28-31. PubMed ID: 6620808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of aminophylline in refractory heart failure: a comparison to the vasodilator sodium nitroprusside, the old and the new.
    DiBianco R; Rosenfeld SP; Katz RJ; Simpson AG; Fletcher RD; Singh S
    Clin Cardiol; 1980 Aug; 3(4):268-75. PubMed ID: 7438579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
    Awan NA; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1127-36. PubMed ID: 6291358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasodilator therapy with a new stable prostacyclin analog, OP-41483, for congestive heart failure due to coronary artery disease and comparison of hemodynamic effects and platelet aggregation with nitroprusside.
    Yui Y; Takatsu Y; Hattori R; Susawa T; Sakaguchi K; Yui N; Kawai C
    Am J Cardiol; 1986 Nov; 58(10):1042-5. PubMed ID: 3535472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 34. RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
    Daly PA; Chatterjee K; Viquerat CE; Parmley WW; Curran D; Scheinbaum M; Anderson S
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1539-44. PubMed ID: 4003296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect.
    Beekman RH; Rocchini AP; Rosenthal A
    Circulation; 1981 Sep; 64(3):553-8. PubMed ID: 7261287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
    Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
    [No Abstract]   [Full Text] [Related]  

  • 37. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of trimazosin on hemodynamics in chronic heart failure.
    Orlando JR; Danahy DT; Lurie M; Aronow WS
    Clin Pharmacol Ther; 1978 Nov; 24(5):531-6. PubMed ID: 359215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
    Massie BM; Cornyn J; Topic N; Loge D; Podolin RA
    Am J Cardiol; 1987 Sep; 60(8):647-53. PubMed ID: 3661429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.